TABLE 5. Changes From Baseline for SCr and eGFR

Iopamidol-370 GroupIodixanol-320 GroupP*
NMean Change±SDNMean Change±SD
*P value for comparison of contrast agent groups based on ANCOVA model.
Total population
    SCr, mg/dL2040.07±0.222100.12±0.230.032
    eGFR, mL/min per 1.73 m2204−2.16±7.86210−4.02±8.100.038
Patients without diabetes mellitus
    SCr, mg/dL1260.07±0.191180.08±0.180.708
    eGFR, mL/min per 1.73 m2126−2.23±7.18118−3.28±8.350.695
Patients with diabetes mellitus
    SCr, mg/dL780.07±0.26920.16±0.270.013
    eGFR, mL/min per 1.73 m278−2.05±8.9092−4.97±7.650.016